Leucine: US-based Leucine nets $7M, helps produce safer medicines with AI
New Jersey-based Leucine uses cutting-edge AI technology to digitise pharmaceutical manufacturing. Now, the company has snapped a $7 million Series A funding round led by Ecolab Inc.
Read full article »
Co-Founder & CEO
Vivek Gera
Leucine is a New York-based AI platform that enables pharmaceutical companies to optimize production and manage compliance.
Read more